ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

5 links1 made here, not in the record8 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03089645MEDI5083 Alone and inCombination WithDurvalumab, Tremelimumab,and/or Docetaxel.MedImmune LLCPhase 1 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSAdvanced Solid TumorsNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSINT016850Entry “MEDI5083 monotherapy”, read by…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDurvalumabEntry “Medi5083 with Durvalumab and D…›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · TestedTestedDocetaxelEntry “Medi5083 with Durvalumab and D…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTremelimumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · partnerBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT016850

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “MEDI5083 monotherapy”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3INT016850Claude Opus 5.5TestedCurrent
Nov 3DurvalumabClaude Opus 5.5Background · partnerCurrent
Nov 3DocetaxelClaude Opus 5.5TestedCurrent
Nov 3Tremelimumabmade hereClaude Opus 5.5Background · partnerCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14Advanced Solid TumorsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18INT016850Rule based · role ruleTestedAgrees
Nov 18DurvalumabRule based · role ruleTestedCurrent
Nov 18DocetaxelRule based · role ruleTestedAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.